Keira F. Anderson-King Baxter

Keira Anderson-King is the Sterility Assurance Specialist for Australia and New Zealand Compounding at Baxter.

Prior to this role, Keira held the position of Microbiology Quality Manager at ANSTO (Australia's only nuclear reactor) where she was responsible for all Microbiology and Sterility Assurance activities across the radiopharmaceutical sections.

Keira has over 7 years experience in developing, validating and performing a range of microbiology test methods (including sterility testing, endotoxin LAL testing, particle counting, bioburden testing and water monitoring). This is in addition to developing and maintaining Sterility Assurance programs (including environmental monitoring, depyrogenation, cleaning and disinfection, media fills, operator qualification, clean room qualification and sterilisation).

Keira has extensive knowledge on the application of Microbiology and Sterility Assurance in the radiopharmaceutical space. Keira has applied this knowledge as part of the Australian Therapeutic Goods Association (TGA) radiopharmaceuticals technical working group, which developed the guidance document 'Manufacture of sterile radiopharmaceuticals labelled with fluorine-18' published in February 2019.